172 related articles for article (PubMed ID: 9511071)
1. Antistaphylococcal activities of quinupristin/dalfopristin in vitro across platelet-fibrin matrices and in experimental endocarditis.
Berthaud N; Huet Y; Diallo N; Desnottes JF
J Antimicrob Chemother; 1997 May; 39 Suppl A():93-8. PubMed ID: 9511071
[TBL] [Abstract][Full Text] [Related]
2. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
Kang SL; Rybak MJ
J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
[TBL] [Abstract][Full Text] [Related]
3. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
[TBL] [Abstract][Full Text] [Related]
4. Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics.
Pavie J; Lefort A; Zarrouk V; Chau F; Garry L; Leclercq R; Fantin B
Antimicrob Agents Chemother; 2002 Sep; 46(9):3061-4. PubMed ID: 12183272
[TBL] [Abstract][Full Text] [Related]
5. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
[TBL] [Abstract][Full Text] [Related]
6. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.
Fantin B; Leclercq R; Garry L; Carbon C
Antimicrob Agents Chemother; 1997 May; 41(5):931-5. PubMed ID: 9145847
[TBL] [Abstract][Full Text] [Related]
7. Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.
Fantin B; Leclercq R; Merlé Y; Saint-Julien L; Veyrat C; Duval J; Carbon C
Antimicrob Agents Chemother; 1995 Feb; 39(2):400-5. PubMed ID: 7726505
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.
Sacar M; Sacar S; Cevahir N; Onem G; Teke Z; Asan A; Turgut H; Adali F; Kaleli I; Susam I; Yaylali YT; Baltalarli A
Tex Heart Inst J; 2010; 37(4):400-4. PubMed ID: 20844611
[TBL] [Abstract][Full Text] [Related]
9. Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.
Entenza JM; Drugeon H; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1995 Jul; 39(7):1419-24. PubMed ID: 7492078
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
[TBL] [Abstract][Full Text] [Related]
12. Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics.
Vouillamoz J; Entenza JM; Féger C; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2000 Jul; 44(7):1789-95. PubMed ID: 10858332
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium.
Hill RL; Smith CT; Seyed-Akhavani M; Casewell MW
J Antimicrob Chemother; 1997 May; 39 Suppl A():23-8. PubMed ID: 9511058
[TBL] [Abstract][Full Text] [Related]
14. A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.
Low DE; Nadler HL
J Antimicrob Chemother; 1997 May; 39 Suppl A():53-8. PubMed ID: 9511063
[TBL] [Abstract][Full Text] [Related]
15. Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus.
Zarrouk V; Bozdogan B; Leclercq R; Garry L; Carbon C; Fantin B
Antimicrob Agents Chemother; 2000 May; 44(5):1168-73. PubMed ID: 10770747
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Cha R; Brown WJ; Rybak MJ
Antimicrob Agents Chemother; 2003 Dec; 47(12):3960-3. PubMed ID: 14638509
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
Rybak MJ; Houlihan HH; Mercier RC; Kaatz GW
Antimicrob Agents Chemother; 1997 Jun; 41(6):1359-63. PubMed ID: 9174199
[TBL] [Abstract][Full Text] [Related]
18. In-vitro bactericidal activity of quinupristin/dalfopristin against adherent Staphylococcus aureus.
Berthaud N; Desnottes JF
J Antimicrob Chemother; 1997 May; 39 Suppl A():99-102. PubMed ID: 9511072
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
López Fornas F; Martínez García F; Pérez Salmeron J; Roldán Conesa D; Cortés Sanchez R; García Alberola A; Ruíz Gómez J; Gómez Gómez J; Valdés Chávarri M
J Antimicrob Chemother; 2001 May; 47(5):623-9. PubMed ID: 11328774
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]